Fig. 2From: Cost-utility analysis of caspofungin and fluconazole for primary treatment of invasive candidiasis and candidemia in EthiopiaDeterministic sensitivity analysis result of fluconazole-initiated treatment followed by caspofungin versus fluconazole-initiated followed by L-AmB. CASPO: Caspofungin; FLU: Fluconazole; L-AmB: Liposomal amphotericin BBack to article page